市場調查報告書
商品編碼
1308508
近距離放射治療市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會及預測Brachytherapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球近距離放射治療市場規模達到8.219億美元。展望未來,IMARC Group預計到2028年,該市場規模將達到10.52億美元,2023-2028年期間的年複合成長率(CAGR)為3.4%。
近距離放射治療(Brachyapytherapy),又稱內放射治療,是一種放射治療方式,通過植入體內癌症腫瘤附近或旁邊的放射源直接輸送射線。放射源產生的伽馬射線聚焦於癌細胞,減少對周圍健康組織的損害。近距離放射治療根據疾病及其損害的嚴重程度分為低劑量率(LDR)和高劑量率(HDR)兩種。低劑量近距離放射治療是將小型放射性種子永久性植入腫瘤內部或周圍,而高劑量近距離放射治療則是在每次治療結束後將放射源從患者體內移除,適用於高危癌症病例。
不同類型癌症發病率的上升是推動全球市場發展的關鍵因素之一。近距離放射治療已被證明是治療宮頸癌、皮膚癌和乳腺癌的一種極為有效的方法,這大大促進了其市場的成長。此外,高品質近距離放射治療設備可對小腫瘤提供精確和極高的局部放射劑量,這提高了患者和醫療專業人員對該療法的接受程度。腫瘤治療技術的進步和廣泛的研發(R&D),如治療新生血管性老年黃斑部病變的試驗,也極大地推動了市場的成長。除此以外,全球醫療旅遊的不斷成長,以及人們對近距離放射治療優勢的認知不斷提高,與手術或體外射束療法(EBT)相比,近距離放射治療的成本效益和治愈率不斷提高,也極大地推動了市場的發展。
IMARC Group的最新報告深入剖析了全球近距離放射治療市場的方方面面。從市場的宏觀概述到行業表現的微觀細節、最新趨勢、主要市場驅動因素和挑戰、SWOT分析、波特五力分析、價值鏈分析等。本報告是業內人士、投資者、研究人員、顧問、商業戰略家以及所有與全球近距離放射治療市場有任何利益關係或計劃以任何方式進入該市場的人士的必讀報告。
The global brachytherapy market size reached US$ 821.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,052.0 Million by 2028, exhibiting a growth rate (CAGR) of 3.4% during 2023-2028.
Brachytherapy, also known as internal radiation therapy, is a form of radiotherapy in which radiation is transported directly through a source implanted near or next to the cancerous tumor in the body. The source produces gamma rays that are focused on cancer cells and reduce the damage to surrounding healthy tissue. Brachytherapy is either administered in Low Dose Rate (LDR) or High Dose Rate (HDR) depending upon the severity of the disease and its damage. For LDR, small radioactive seeds are implanted permanently in or around the tumor, whereas, for HDR, radioactive sources are removed from the patient's body at the termination of each session and is used in the cases of high-risk cancers.
The rising prevalence of different types of cancer is one of the key factors driving the global market. Brachytherapy has been proven to be an extremely effective treatment option for cervical, skin and breast cancers, which is contributing significantly to its market growth. Furthermore, the availability of high-quality brachytherapy equipment that provides accurate and extremely localized doses of radiation to small tumors has enhanced the acceptance of the therapy amongst patients and medical professionals alike. Technological advancements in oncology treatments and extensive research and development (R&D), such as trials for treating neovascular age-related macular degeneration, have also provided a significant boost to the market growth. In addition to this, growing medical tourism across the globe, along with increasing awareness about the advantages of brachytherapy and its cost-effectiveness and increasing cure rate as compared to surgery or external beam therapy (EBT), is also significantly driving the market.
IMARC Group's latest report provides a deep insight into the global brachytherapy market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global brachytherapy market in any manner.
IMARC Group provides an analysis of the key trends in each sub-segment of the global brachytherapy market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on service type, technology, mode of procurement and end-user.
History and Physical Report
Discharge Summary
Operative Note or Report
Consultation Report
Others (Pathology Report, Radiology Report, etc.)
EMR/EHR
PACS
RIS
SRT
Others
Outsourcing
Offshoring
Both
Hospitals
Clinics
Clinical Laboratories
Academic Medical Centers
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analyzed the competitive landscape of the market with some of the key players being Acusis Software India Pvt Ltd., Transcend Services, Inc., Naunce Communications, Inc., MModal Global Services Pvt. Ltd., iMedX Information Services Pvt. Ltd., Global Medical Transcription LLC, nThrive Solutions LLC, MTBC (CareCloud, Inc.), Medi-Script Plus and Transtech Medical Solutions LLC.